Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05897229
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-15
First Post:
2023-06-07
Brief Title:
Palliative Care in Patients With COVID-19 Analysis of Costs of Hospitalization in Wards and Intensive Care Units
Sponsor:
University of Sao Paulo General Hospital
Organization:
University of Sao Paulo General Hospital
Study Overview
Official Title:
Palliative Care in Patients With COVID-19 Analysis of Costs of Hospitalization in Wards and Intensive Care Units
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The confrontation of COVID-19 foreshadowed a serious crisis of scarce health resources worldwide To assist in this confrontation the Palliative Care Scientific Technical Core of the Clinical Hospital School of Medicine Sao Paulo University USP elaborated a Triage Protocol for Palliative Care PALI-COVID Tool and it was possible to categorize the patients in three groups according to the risk of death and needs of Palliative Care PC through the clinical evaluation of the patient that also directed them to the hospitalization resource according to their need ward x ICU
Detailed Description:
The patients grouped as with higher risk of death and PC needs green group by PALI-COVID Tool were those with a profile of end-of-life signs of clinical deterioration and risk of death on admission and thus indicated for admission to the COVID-19 Palliative Care Inpatient Unit however some were admitted to the ICU Objective to analyze the direct costs of hospitalization of COVID-19 Palliative Care patients in Palliative Care Inpatient Unit and ICU screened as green group by the COVID-19 Screening Protocol developed in the institution Methods observational cross-sectional and retrospective study of the service database of patients over 18 years of age screened as the green group PALI-COVID The variables to be investigated are related to sociodemographic and clinical data length of stay and hospitalization scenarios time to call for PC outcome and costs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None